Wednesday, January 13, 2021

RPB Grant Given To UTHSC and Zeiss UVClean On January 17 Show


Dr. Penny Asbell (University of Tennessee Health Science Center - Memphis, TN)

Zeiss UVClean (Zeiss Vision Care)


Dr. Penny Asbell of the University of Tennessee Health Science Center at Memphis's Hamilton Eye Institute explains the purpose of a $300,000 grant that the institution received from Research to Prevent Blindness.

Then, Robert Spirito of Zeiss Vision Care explains how a cooler-size unit called the Zeiss UVClean, uses ultraviolet to clean and disinfect lenses.

1/17/2021 Podcast (Click Image Below)

Wednesday, December 23, 2020

Gene Therapy To Prevent Degeneration Of Cone Photoreceptors In Mice On December 27 Show

Dr. Nicolas Bazan (LSU Health Sciences - New Orleans, LA)

Dr. Nicolas Bazan of LSU Health Sciences Center in New Orleans discusses how inhibiting the PATP4 protein associated with the RPE65 gene can prevent the degeneration of cone photoreceptors in mice.

12/27/2020 Podcast (Click Image Below) 

Monday, December 14, 2020

EZ2See Products and the Uniqueness of Corneal Schwann Cells On December 20 Show

Edward Cohen (EZ2See Products - Rochester, MN)

Dr. Royce Mohan (University of Connecticut School of Medicine - Farmington, CT)


Edward Cohen, founding owner of EZ2See Products in Rochester, Minnesota, goes over its large print weekly calendar, high contrast sticky note pads, and Independent Living Aids bold, no bleed pen.

Dr. Royce Mohan of the University of Connecticut School of Medicine explains the uniqueness of corneal Schwann cells and their role in nerve regeneration and sensory function.

12/20/2020 Podcast (Click Image Below)

Thursday, November 19, 2020

Orasis's CSF-1 Eye Drop To Treat Presbyopia and Whether Cornea Is Susceptible To COVID-19 Infection

Elad Kedar, CEO (Orasis Pharmaceuticals -Herzliya, Israel)

Dr. Jonathan Miner (Washington University School of Medicine - St. Louis, MO)

Orasis Pharmaceuticals CEO Elad Kedar discusses its eye drop, CSF-1, which has undergone NEAR-1 and NEAR-2 clinical trials to treat presbyopia that adversely affects near vision as the eyes age.

Then, Dr. Jonathan Miner of the Washington University School of Medicine in St. Louis explains research into whether the cornea is suspectible to COVID-19 infection.

November 22 Podcast (Click Below)

Friday, November 6, 2020

How Eyes Adapt To Maintain Vision During Early Retinal Degeneration and COVID-19's Effects On Care of Glaucoma and RP Patients

Dr. Frans Vinberg (University of Utah - Salt Lake City, UT)

Dr. Daniel Laroche (Advanced Eye Care of New York - New York, NY)


Dr. Frans Vinberg of the University of Utah School of Medicine explains how eyes can adapt to maintain vision during early stages of retinal degenerative disease.

Then, Advanced Eye Care of New York's Dr. Daniel Laroche discusses COVID-19's effects on the care of glaucoma and retinitis pigmentosa patients, especially those of color.

11/8/2020 Podcast (Click Below)

Friday, October 30, 2020

Using SLT at Low Energy To Potentially Treat Glaucoma And An Experimental Compound To Potential Treat Retinopathy

Dr. Tony Realini (West Virginia University - Morgantown, WV)

Dr. Chris Schafer  (Oklahoma Medical Research Foundation - Oklahoma City, OK)


Dr. Tony Realini of West Virginia University goes over a study on mice, which compares using selective laser trabeculoplasty (SLT) at standard and low energy levels to potentially treat glaucoma.


Then, the Oklahoma Medical Research Foundation's Dr. Chris Schafer explains how an experimental compound was developed to target a specific class of proteins in mice to potentially treat retinopathy.

11/1/2020 Podcast (Click Below) 

Wednesday, October 14, 2020

Surveys Covering The Pandemic's Effects On Those With Low Vision On October 18 Show

Tom Brunner (Glaucoma Research Foundation - San Francisco, CA)

Dr. L. Penny Rosenblum (American Foundation for the Blind - Tucson, AZ)


Tom Brunner of the Glaucoma Research Foundation discusses the Glaucoma Impact Survey, which explored the experiences and concerns of glaucoma patients during the early months of the COVID-19 pandemic.

Then, Dr. L. Penny Rosenblum of the American Foundation of the Blind explains the Flatten Inaccessibility Survey, which studied the challenges of those with low vision during the early period of pandemic with regards to access to transportation, health care, employment, and education.

10/18/2020 Podcast (Click Link Below) 

Blog Archive

About Me

3030 Poplar Ave. Memphis, TN 38111